Tags: Diabetes | oral | insulin | diabetes | ORMD-0801 | test

Oral Insulin Effective in Trial

Wednesday, 22 October 2014 12:53 PM


Oramed Pharmaceuticals Inc said its oral insulin capsule appeared to be safe and was well-tolerated by diabetics in a mid-stage trial.
The Israeli biotechnology company's shares jumped about 10 percent to $8.73 before the bell on Wednesday.
The treatment, ORMD-0801, was being tested in 25 patients with type 1 diabetes, once known as juvenile diabetes.
It is a chronic condition in which the pancreas produces little or no insulin, a hormone needed to allow sugar to enter cells to produce energy.
ORMD-0801 is also being developed for use in type 2 diabetes, the most common form of the disease, where the body does not use insulin properly.
 

© 2019 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
Oramed Pharmaceuticals Inc said its oral insulin capsule appeared to be safe and was well-tolerated by diabetics in a mid-stage trial. The Israeli biotechnology company's shares jumped about 10 percent to $8.73 before the bell on Wednesday. The treatment, ORMD-0801, was being...
oral, insulin, diabetes, ORMD-0801, test
107
2014-53-22
Wednesday, 22 October 2014 12:53 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved